These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Assessing sociability using the Three-Chamber Social Interaction Test and the Reciprocal Interaction Test in a genetic mouse model of ASD. Szabó J; Renczés E; Borbélyová V; Ostatníková D; Celec P Behav Brain Funct; 2024 Sep; 20(1):24. PubMed ID: 39342245 [TBL] [Abstract][Full Text] [Related]
23. Visual systemizing preference in children with autism: A randomized controlled trial of intranasal oxytocin. Strathearn L; Kim S; Bastian DA; Jung J; Iyengar U; Martinez S; Goin-Kochel RP; Fonagy P Dev Psychopathol; 2018 May; 30(2):511-521. PubMed ID: 28712371 [TBL] [Abstract][Full Text] [Related]
24. Mice with reduced NMDA receptor expression: more consistent with autism than schizophrenia? Gandal MJ; Anderson RL; Billingslea EN; Carlson GC; Roberts TP; Siegel SJ Genes Brain Behav; 2012 Aug; 11(6):740-50. PubMed ID: 22726567 [TBL] [Abstract][Full Text] [Related]
25. The NMDA receptor modulator zelquistinel durably relieves behavioral deficits in three mouse models of autism spectrum disorder. Fonteneau M; Brugoux A; Jaccaz D; Donello JE; Banerjee P; Le Merrer J; Becker JA Neuropharmacology; 2024 May; 248():109889. PubMed ID: 38401792 [TBL] [Abstract][Full Text] [Related]
26. Serotonin 6 receptor blockade reduces repetitive behavior in the BTBR mouse model of autism spectrum disorder. Amodeo DA; Oliver B; Pahua A; Hitchcock K; Bykowski A; Tice D; Musleh A; Ryan BC Pharmacol Biochem Behav; 2021 Jan; 200():173076. PubMed ID: 33220385 [TBL] [Abstract][Full Text] [Related]
27. Autism-Like Behavior in BTBR Mice Is Improved by Electroconvulsive Therapy. Hagen E; Shprung D; Minakova E; Washington J; Kumar U; Shin D; Sankar R; Mazarati A Neurotherapeutics; 2015 Jul; 12(3):657-66. PubMed ID: 25916397 [TBL] [Abstract][Full Text] [Related]
28. Neonatal curcumin treatment restores hippocampal neurogenesis and improves autism-related behaviors in a mouse model of autism. Zhong H; Xiao R; Ruan R; Liu H; Li X; Cai Y; Zhao J; Fan X Psychopharmacology (Berl); 2020 Dec; 237(12):3539-3552. PubMed ID: 32803366 [TBL] [Abstract][Full Text] [Related]
29. Acute, chronic and conditioned effects of intranasal oxytocin in the mu-opioid receptor knockout mouse model of autism: Social context matters. Pantouli F; Pujol CN; Derieux C; Fonteneau M; Pellissier LP; Marsol C; Karpenko J; Bonnet D; Hibert M; Bailey A; Le Merrer J; Becker JAJ Neuropsychopharmacology; 2024 Nov; 49(12):1934-1946. PubMed ID: 39020142 [TBL] [Abstract][Full Text] [Related]
30. Pharmacological modulation of AMPA receptor rescues social impairments in animal models of autism. Kim JW; Park K; Kang RJ; Gonzales ELT; Kim DG; Oh HA; Seung H; Ko MJ; Kwon KJ; Kim KC; Lee SH; Chung C; Shin CY Neuropsychopharmacology; 2019 Jan; 44(2):314-323. PubMed ID: 29899405 [TBL] [Abstract][Full Text] [Related]
31. Social deficits, stereotypy and early emergence of repetitive behavior in the C58/J inbred mouse strain. Ryan BC; Young NB; Crawley JN; Bodfish JW; Moy SS Behav Brain Res; 2010 Mar; 208(1):178-88. PubMed ID: 19941908 [TBL] [Abstract][Full Text] [Related]
32. C57BL/6J bone marrow transplant increases sociability in BTBR T Schwartzer JJ; Onore CE; Rose D; Ashwood P Brain Behav Immun; 2017 Jan; 59():55-61. PubMed ID: 27235929 [TBL] [Abstract][Full Text] [Related]
33. Exogenous and evoked oxytocin restores social behavior in the Cntnap2 mouse model of autism. Peñagarikano O; Lázaro MT; Lu XH; Gordon A; Dong H; Lam HA; Peles E; Maidment NT; Murphy NP; Yang XW; Golshani P; Geschwind DH Sci Transl Med; 2015 Jan; 7(271):271ra8. PubMed ID: 25609168 [TBL] [Abstract][Full Text] [Related]
34. Early Correction of N-Methyl-D-Aspartate Receptor Function Improves Autistic-like Social Behaviors in Adult Shank2 Chung C; Ha S; Kang H; Lee J; Um SM; Yan H; Yoo YE; Yoo T; Jung H; Lee D; Lee E; Lee S; Kim J; Kim R; Kwon Y; Kim W; Kim H; Duffney L; Kim D; Mah W; Won H; Mo S; Kim JY; Lim CS; Kaang BK; Boeckers TM; Chung Y; Kim H; Jiang YH; Kim E Biol Psychiatry; 2019 Apr; 85(7):534-543. PubMed ID: 30466882 [TBL] [Abstract][Full Text] [Related]
35. Oxytocin in animal models of autism spectrum disorder. Peñagarikano O Dev Neurobiol; 2017 Feb; 77(2):202-213. PubMed ID: 27603327 [TBL] [Abstract][Full Text] [Related]
36. NEXMIF/KIDLIA Knock-out Mouse Demonstrates Autism-Like Behaviors, Memory Deficits, and Impairments in Synapse Formation and Function. Gilbert J; O'Connor M; Templet S; Moghaddam M; Di Via Ioschpe A; Sinclair A; Zhu LQ; Xu W; Man HY J Neurosci; 2020 Jan; 40(1):237-254. PubMed ID: 31704787 [TBL] [Abstract][Full Text] [Related]
37. Neural modulation of social reinforcement learning by intranasal oxytocin in male adults with high-functioning autism spectrum disorder: a randomized trial. Kruppa JA; Gossen A; Oberwelland Weiß E; Kohls G; Großheinrich N; Cholemkery H; Freitag CM; Karges W; Wölfle E; Sinzig J; Fink GR; Herpertz-Dahlmann B; Konrad K; Schulte-Rüther M Neuropsychopharmacology; 2019 Mar; 44(4):749-756. PubMed ID: 30390065 [TBL] [Abstract][Full Text] [Related]
38. Beta-carotene as a novel therapy for the treatment of "Autistic like behavior" in animal models of Autism. Avraham Y; Berry EM; Donskoy M; Ahmad WA; Vorobiev L; Albeck A; Mankuta D Behav Brain Res; 2019 May; 364():469-479. PubMed ID: 28963040 [TBL] [Abstract][Full Text] [Related]
39. The effects of a course of intranasal oxytocin on social behaviors in youth diagnosed with autism spectrum disorders: a randomized controlled trial. Guastella AJ; Gray KM; Rinehart NJ; Alvares GA; Tonge BJ; Hickie IB; Keating CM; Cacciotti-Saija C; Einfeld SL J Child Psychol Psychiatry; 2015 Apr; 56(4):444-52. PubMed ID: 25087908 [TBL] [Abstract][Full Text] [Related]
40. Fluoxetine but not risperidone increases sociability in the BTBR mouse model of autism. Chadman KK Pharmacol Biochem Behav; 2011 Jan; 97(3):586-94. PubMed ID: 20863848 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]